Binding of calmodulin to the carboxy-terminal region of p21 induces nuclear accumulation via inhibition of protein kinase C-mediated phosphorylation of Ser153

Molecular and Cellular Biology

Volumn 25, Issue 16, 2005, Pages 7364-7374

  Rodríguez Vilarrupla, Aina ^a   Jaumot, Montserrat ^a   Abella, Neus ^a   Canela, Núria ^a   Brun, Sonia ^a   Díaz, Carmen ^a   Estanyol, Josep M ^a   Bachs, Oriol ^a   Agell, Neus ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ASPARTIC ACID; CALMODULIN; MUTANT PROTEIN; PROTEIN KINASE C; PROTEIN P21; PROTEIN P21S153A; SERINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUTATION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; STRESS FIBER; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING; WILD TYPE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BLOTTING, WESTERN; CALMODULIN; CELL CYCLE PROTEINS; CELL NUCLEUS; COS CELLS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLUTATHIONE TRANSFERASE; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; MICE; MICROSCOPY, FLUORESCENCE; MUTAGENESIS, SITE-DIRECTED; MUTATION; NIH 3T3 CELLS; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN BINDING; PROTEIN KINASE C; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; SERINE; SUBCELLULAR FRACTIONS;

EID: 23344441826     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.16.7364-7374.2005     Document Type: Article

References (61)

1. Agell, N., R. Aligue, V. Alemany, A. Castro, M. Jaime, M. J. Pujol, E. Rius, J. Serratosa, M. Taules, and O. Bachs. 1998. New nuclear functions for calmodulin. Cell Calcium 23:115-121.
2. Cip1 promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J. Biol. Chem. 277:8517-8523.
3. Cip1/WAF1 in monocytic differentiation. EMBO J. 18:1223-1234.
4. WAF1. Curr. Biol. 7:71-80.
5. Besson, A., R. K. Assoian, and J. M. Roberts. 2004. Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors? Nat. Rev. Cancer 4:948-955.
6. WAF1/CIP1 is an early event in the development of pancreatic intraepithelial neoplasia. Cancer Res. 61:8830-8837.
7. Blagosklonny, M. V. 2002. Are p27 and p21 cytoplasmic oncoproteins? Cell Cycle 1:391-393.
8. Bogatkevich, G. S., E. Gustilo, J. C. Dates, C. Feghali-Bostwick, R. A. Harley, R. M. Silver, and A. Ludwicka-Bradley. 2005. Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol. 288:L190-L201.
9. 8a.Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
10. 2+-calmodulin and protein kinase Cs: a hypothetical synthesis of their conflicting convergences on shared substrate domains. Trends Neurosci. 22:12-16.
11. Chen, J., P. K. Jackson, M. W. Kirschner, and A. Dutta. 1995. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374:386-388.
12. kip1 CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1571-1583.
13. Cheung, W. Y. 1980. Calmodulin plays a pivotal role in cellular regulation. Science 207:19-27.
14. Chin, D., and A. R. Means. 2000. Calmodulin: a prototypical calcium sensor. Trends Cell Biol. 10:322-328.
15. Coqueret, O. 2003. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 13:65-70.
16. WAF1/Cip1: more than a break to the cell cycle? Biochim. Biophys. Acta 1471:M43-M56.
17. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E, Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
18. cip1 on cyclin E-cyclin-dependent kinase 2 activity. J. Biol. Chem. 274:33161-33165.
19. Cip1 is a determinant for target protein recognition. Chembiochem 4:863-869.
20. Cartel, A. L., and A. L. Tyner. 2002. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol. Cancer Ther. 1:639-649.
21. Cip1 cyclin-dependent kinase inhibitor. Oncogene 10:2281-2287.
22. 1 cyclin-dependent kinases. Cell 75:805-816.
23. Harreman, M. T., T. M. Kline, H. G. Milford, M. B. Harben, A. E. Hodel, and A. H. Corbett. 2004. Regulation of nuclear import by phosphorylation adjacent to nuclear localization signals. J. Biol. Chem. 279:20613-20621.
24. Ikura, M. 1996. Calcium binding and conformational response in EF-hand proteins. Trends Biochem. Sci. 21:14-17.
25. Kashiwagi, M., M. Ohba, H. Watanabe, K. Isbino, K. Kasahara, Y. Sanai, Y. Taya, and T. Kuroki. 2000. PKC eta associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk2 kinase in keratinocytes. Oncogene 19:6334-6341.
26. Cip1. Oncogene 11:1675-1683.
27. cip1/waf1/sdi1 in DNA replication and transcription. J. Biol. Chem. 275:10477-10483.
28. Klee, C. B., H. Ren, and X. Wang. 1998. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J. Biol. Chem. 273:13367-13370.
29. Klee, C. B., and T. Vanaman. 1982. Calmodulin. Adv. Protein Chem. 35:213-321.
30. La Baer, J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:847-862.
31. Laemmli, U. K. 1970. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 227:680-685.
32. cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/Cofilin pathway. J. Biol. Chem. 279:1885-1891.
33. cip/WAF1 and promotes cell survival. J. Biol. Chem. 277:11352-11361.
34. Lu, K. P., and A. R. Means. 1993. Regulation of the cell cycle by calcium and calmodulin. Endocr. Rev. 14:40-58.
35. Cip1. Nature 375:159-161.
36. 2 phase of the cell cycle. J. Biol. Chem. 275:23181-23186.
37. Means, A. R. 2000. Regulatory cascades involving calmodulin-dependent protein kinases. Mol. Endocrinol. 14:4-13.
38. Means, A. R., and J. R. Dedman. 1980. Calmodulin-an intracellular calcium receptor. Nature 285:73-77.
39. Mercer, S. E., D. Z. Ewton, X. Deng, S. Lim, T. R. Mazur, and E. Friedman. Mirk/dyrk1B mediates survival during the differentiation of C2C12 myoblasts. J. Biol. Chem., in press.
40. Sdi1/CIP1/WAF1. EMBO J 14:555-563.
41. Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
42. cip1 and consequences of its mutation on cell proliferation. FEBS Lett. 531:319-323.
43. Scott, M. T., A. Ingram, and K. L. Ball. 2002. PDK1-dependent activation of atypical PKC leads to degradation of the p21 tumour modifier protein. EMBO J. 21:6771-6780.
44. Waf1/Cip1 modulates proliferating cell nuclear antigen binding. J. Biol. Chem. 275:11529-11537.
45. 1-phase progression. Genes Dev. 13:1501-1512.
46. Shim, J., H. Lee, J. Park, H. Kim, and E. J. Choi. 1996. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 381:804-806.
47. Soderling, T. R. 1999. The Ca-calmodulin-dependent protein kinase cascade. Trends Biochem. Sci. 24:232-236.
48. Waf1/Cip1/Sdi1 C-terminal domain bound to Cdk4. J. Biomol. Struct. Dyn. 19:419-427.
49. WAF1 and IAP gene family ILP. Oncogene 17:931-939.
50. Suzuki, A., Y. Tsutomi, N. Yamamoto, T. Shibutani, and K. Akahane. 1999. Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death. Mol. Cell. Biol. 19:3842-3847.
51. Cip1/WAF1 regulates neurite remodeling by inhibiting Rho-kinase activity. J. Cell Biol. 158:321-329.
52. 1. J. Biol. Chem. 273:33279-33286.
53. Cip1 and is involved in the regulation of its nuclear localization. J. Biol. Chem. 274:24445-24448.
54. Timchenko, N. A., T. E. Harris, M. Wilde, T. A. Bilyeu, B. L. Burgess-Beusse, M. J. Finegold, and G. J. Darlington. 1997. CCAAT/enhancer binding protein α regulates p21 protein and hepatocyte proliferation in newborn mice. Mol. Cell. Biol. 17:7353-7361.
55. WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J. 20:2367-2375.
56. Villalonga, P., C. López-Alcalá, M. Bosch, A. Chiloeches, N. Rocamora, J. Gil, R. Marais, C. J. Marshall, O. Bachs, and N. Agell. 2001. Calmodulin binds to K-Ras but not to H- or N-Ras, and modulates its downstream signaling. Mol. Cell. Biol. 21:7345-7354.
57. Waga, S., G. J. Hannon, D. Beach, and B. Stillman. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578.
58. 2+-binding and structural dynamics in the functions of calmodulin. Annu. Rev. Physiol. 56:213-236.
59. WAF1/CIP1 in breast cancer: association with prognosis. Eur. J. Cancer 37:2405-2412.
60. Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients. Clin. Cancer Res. 10:3815-3824.
61. Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 3:245-252.